Ganaxolone versus Phenobarbital for Neonatal Seizure Management

- Miller, Suzanne L., Bennet, Laura, Hirst, Jonathan J., Walker, David W., Hunt, Rodney W., Jenkin, Graham, Wong, Flora, Malhotra, Atul, Fahey, Michael C., Yawno, Tamara, Sutherland, Amy E., Pham, Yen, McDonald, Courtney, Castillo-Melendez, Margie, Allison, Beth J., Mihelakis, Jamie, Nitsos, Ilias, Boyd, Ben J.

Effect of Treatment of Clinical Seizures vs Electrographic Seizures in Full-Term and Near-Term Neonates: A Randomized Clinical Trial

- Hunt, Rod W., Liley, Helen G., Badawi, Nadia, Wong, Flora Y., Osborn, David A., Rajadurai, Victor Samuel, Dargaville, Peter A., Headley, Bevan, Wright, Ian, Colditz, Paul B., Wagh, Deepika, Schembri, Rachel, Lee, Katherine J., Shearman, Andrew D., Francis-Pester, Samantha, deWaal, Koert, Cheong, Jeanie Y. L., Olischar, Monika

Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients

- Climans, Seth A., Brandes, Alba A., Phillips, Claire, Roa, Wilson, Wick, Wolfgang, Winch, Chad, Mason, Warren P., Cairncross, J. Gregory, Ding, Keyue, Fay, Michael, Laperriere, Normand, Menten, Johan, Nishikawa, Ryo, O'Callaghan, Christopher J., Perry, James R.

IQSEC2 mutation update and review of the female-specific phenotype spectrum including intellectual disability and epilepsy

- Shoubridge, Cheryl, Harvey, Robert J., Dudding-Byth, Tracy

Desvenlafaxine overdose and the occurrence of serotonin toxicity, seizures and cardiovascular effects

- Cooper, J. M., Brown, J. A., Cairns, R., Isbister, G. K.

Germline de novo mutations in GNB1 cause severe neurodevelopmental disability, hypotonia, and seizures

- Petrovski, Slavé, Kury, Sébastien, Besnard, Thomas, Becraft, Emily, Wadley, Alexandrea, Politi, Anya Revah, Colombo, Sophie, Zhu, Xiaolin, Ren, Zhong, Andrews, Ian, Dudding-Byth, Tracy, Schneider, Amy L., Myers, Candace T., Anyane-Yeboa, Kwame, Cogné, Benjamin, Bialer, Martin, Xia, Fan, Hemati, Parisa, Riviello, James, Mehaffey, Michele